Table 1 Characteristics of patients with severe aplastic anemia
Patient no. | Sex/age (years) | Earlier therapy | PRC/plt transfusion (no. of units) | Time to HSCT (months) | Plt Ab | CMV IgG donor/ recipient | Donor gender | HLA mismatch | ABO donor/ recipient |
|---|---|---|---|---|---|---|---|---|---|
1 | F/41 | Anabolic hormone | 25/33 | 2 | Positive | +/+ | M | 0 | O/O |
2 | M/19 | ATG, CYA | 22/29 | 7 | Negative | +/+ | F | 0 | A/A |
3 | M/35 | None | 17/19 | 5 | Negative | +/+ | F | 0 | A/A |
4 | M/44 | Anabolic hormone, prednisolone | 22/18 | 15 | Negative | −/− | M | 0 | A/A |
5 | F/52 | ATG, cyclosporinA, anabolic hormone, FK-506 | 370/449 | 23 | Negative | +/+ | M | 0 | AB/AB |
